Religrast 300 mcg Injection
$14,72
$5,54
Religrast 300 mcg Injection is a synthetic version of human granulocyte colony-stimulating factor (G-CSF), designed to enhance the production of white blood cells in the body. This medication is particularly beneficial for patients undergoing chemotherapy, as it helps to bolster their immune system and minimize the risk of infections during treatment. However, it is crucial to note that individuals with certain blood disorders should avoid using this injection due to potential complications. By stimulating the bone marrow to produce more neutrophils, Religrast aids in maintaining a healthier white blood cell count, which is vital for fighting off infections. While generally well-tolerated, some users may experience common side effects, so monitoring is advised. Always consult with your healthcare provider to ensure that Religrast is appropriate for your treatment plan. With its targeted action and effectiveness, this injection plays a significant role in supporting patients through the challenges of cancer therapy.
數量
Active Pharmaceutical Ingredient
Uses
• Religrast 300 mcg injection is primarily utilized in patients undergoing myelosuppressive chemotherapy for cancer treatment. It plays a crucial role in reducing the risk of infections characterized by febrile neutropenia. By boosting the production of white blood cells, Religrast 300 mcg injection helps maintain the immune system during intense chemotherapy regimens. This support is essential for patients with non-myeloid malignancies who are at a higher risk for severe neutropenia.
• In the context of cancer therapy, Religrast 300 mcg injection is administered to enhance the recovery of neutrophil counts. Neutrophils are vital for fighting infections, and their depletion can lead to serious complications. By facilitating quicker recovery of these cells, Religrast 300 mcg injection enables patients to continue their chemotherapy cycles with less interruption. This not only helps in managing the side effects of treatment but also improves overall patient outcomes.
• Religrast 300 mcg injection is particularly beneficial for patients experiencing a significant drop in white blood cell counts due to chemotherapy. It aids in mitigating the incidence of febrile neutropenia, a condition that can lead to prolonged hospital stays and additional treatments. By administering Religrast 300 mcg injection, healthcare providers can help patients maintain their treatment schedules more effectively. This proactive approach is vital for optimizing the therapeutic benefits of cancer treatments.
• For individuals receiving anticancer drugs that are known to cause severe neutropenia, Religrast 300 mcg injection serves as an important therapeutic agent. It is designed to stimulate the bone marrow to produce more neutrophils, thereby enhancing the body's ability to combat infections. The timely use of Religrast 300 mcg injection can prevent complications associated with low white blood cell counts. As a result, patients can experience improved safety and efficacy during their cancer treatment journey.
Benefits
Religrast 300 mcg Injection is designed to stimulate the production of white blood cells, which are an important part of the body's immune system. By attacking and eliminating harmful bacteria and viruses, white blood cells help protect the body from infection and disease. By increasing the amount of white blood cells in the body.
Filgrastim Injection 300 mcg may help reduce the risk of infection in people with neutropenia. Neutropenia is a condition characterized by a low number of neutrophils, a type of white blood cell.
Religrast 300 mcg Injection helps reduce the duration of neutropenia and neutropenia-related hospitalizations in people receiving chemotherapy for cancer. It may also be used to reduce the incidence of febrile neutropenia, which is a potentially serious complication of chemotherapy that is associated with fever and a low white blood cell count.
Overall, the main benefit of Religrast 300 mcg Vial is its ability to help boost the body's immune system and protect it from infection.
Side Effects
Like all medicines, Filgrastim Injection 300 mcg may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Oropharyngeal pain
• Hair loss
• Fatigue
• Diarrhea
• Constipation
• Decreased appetite
• Cough
• Breathing problems
• Injection site reactions (pain, swelling, redness)
Common Side Effects
• Bone pain
• Weakness
• Headache
• Rash
• Nausea
• Increased lactate dehydrogenase level in blood
• Vomiting
• Increased uric acid level in the blood
How To Use
Religrast 300 mcg Injection is administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of Religrast Injection will depend on the clinical condition of the patient's age and medical history and other factors. Kindly do not self-administer now.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Religrast Injection. May increase the risk of liver damage. It is best to avoid or limit alcohol consumption while taking medication.
• Kidney: The use of Religrast 300 mcg Vial is safe in patients with kidney disease. No dose adjustment of Religrast 300 mcg is recommended. If you notice any side effects, contact your doctor.
• Breastfeeding: It is not known whether Religrast 300 mcg is excreted in breast milk. If you are breastfeeding and using Religrast 300 mcg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing breastfeeding. Your doctor can help you make the best decision for you, your health and the health of your baby.
• Liver: Filgrastim Injection 300 mcg is safe to use in patients with liver disease. No dose adjustment of Religrast Injection is recommended. If you notice any side effects, contact your doctor.
• Pregnancy: The use of Religrast 300 mcg Injection during pregnancy may not be safe, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the possible risks and benefits of using Religrast 300 mcg Vial during pregnancy. Your doctor can help you make the best decision for you, your health and the health of your baby.
• Driving: Religrast 300 mcg Injection is unlikely to affect your ability to drive or use machines. If you experience side effects such as dizziness or drowsiness while taking Filgrastim Injection 300 mcg, it is important not to drive a car or operate heavy machinery until the side effects have subsided.